Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Disease Progression × Valproic Acid × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Urologic Neoplasms 1 Thyroid Neoplasms 1 Soft Tissue Neoplasms 1 Sarcoma 1 Recurrence 1 Pharyngeal Neoplasms 1 Neurofibromatosis 2 1 Neoplasms, Mesothelial 1 Neoplasms 1 Myelodysplastic Syndromes 1 Mouth Neoplasms 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Acute 1 Erdheim-Chester Disease 1 Endocrine Gland Neoplasms 1 Castleman Disease 1 Carcinoma, Transitional Cell 1 Cancer That is Associated With a Chronic Viral Infection 1 Breast Neoplasms 1

Interventions

Nivolumab 3 Cisplatin 3 capivasertib 2 Radiosurgery 2 Gemcitabine 2 Carboplatin 2 tivozanib 1 regorafenib 1 niraparib 1 lutetium Lu 177 dotatate 1 fludarabine phosphate 1 fludarabine 1 encorafenib 1 durvalumab 1 copanlisib 1 cemiplimab 1 axicabtagene ciloleucel 1 avasopasem manganese 1 Taxes 1 Receptors, Interleukin-6 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Image-Guided 1 Radiotherapy 1 RNA-Seq 1 Pemetrexed 1 Paclitaxel 1 Oxaliplatin 1 Multiparametric Magnetic Resonance Imaging 1 Leucovorin 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡